StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
83
This month
1
This year
6
Publishing Date
2023 - 01 - 18
1
2023 - 01 - 16
1
2023 - 01 - 11
1
2023 - 01 - 04
1
2023 - 01 - 03
1
2022 - 12 - 28
1
2022 - 12 - 06
1
2022 - 12 - 05
1
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 17
1
2022 - 11 - 15
1
2022 - 11 - 01
1
2022 - 09 - 07
1
2022 - 08 - 29
1
2022 - 08 - 19
1
2022 - 08 - 17
1
2022 - 08 - 12
1
2022 - 08 - 11
1
2022 - 08 - 02
1
2022 - 07 - 28
1
2022 - 07 - 20
1
2022 - 07 - 19
1
2022 - 07 - 01
1
2022 - 06 - 24
2
2022 - 06 - 22
2
2022 - 06 - 20
1
2022 - 05 - 27
1
2022 - 05 - 24
1
2022 - 05 - 09
1
2022 - 05 - 05
1
2022 - 05 - 03
1
2022 - 04 - 25
1
2022 - 04 - 19
1
2022 - 03 - 30
1
2022 - 03 - 14
1
2022 - 03 - 10
1
2022 - 03 - 04
1
2021 - 12 - 06
2
2021 - 11 - 02
1
2021 - 10 - 29
1
2021 - 10 - 28
1
2021 - 10 - 22
1
2021 - 10 - 13
1
2021 - 10 - 05
1
2021 - 10 - 01
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 08
1
2021 - 08 - 24
1
2021 - 08 - 11
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 07 - 20
1
2021 - 06 - 08
1
2021 - 05 - 10
1
2021 - 05 - 06
1
2021 - 05 - 04
1
2021 - 03 - 22
1
2021 - 03 - 07
1
Sector
Consumer non-durables
1
Electronic technology
1
Health services
1
Health technology
83
Manufacturing
6
N/a
4
Process industries
1
Producer manufacturing
2
Professional, scientific, and technical services
1
Tags
Acute myeloid leukemia
2
Agreement
2
Als
1
Alzheimer's
1
America
1
Aml
2
Approval
2
Beacon
1
Beyond
1
Biocanada
1
Biocapital
1
Biosimilar
3
Biotech
1
Biotech-bay
2
Breast
1
Business
2
Cancer
3
Car-t
1
Ceo
1
Chmp
3
Collaboration
1
Device
2
Diabetes
2
Diabetic
1
Diagnostics
2
Disease
8
Drug
5
Drug delivery
1
Earnings
9
Ema
1
Fabhalta
1
Fda
3
Fda approval
1
Financial
3
Financial results
5
First
1
Genetown
1
Global
7
Growing
3
Growth
14
Health
2
Heart
2
Leqvio
2
Leukemia
3
License
2
Market
27
Myeloid leukemia
2
N/a
61
Novartis
11
People
2
Pharma
3
Positive
3
Report
10
Research
9
Results
12
Risk
3
Therapeutics
10
Therapy
6
Treatment
7
Update
2
Entities
3m company
1
Abbott laboratories
5
Abbvie inc.
10
Acrivon therapeutics, inc.
1
Adaptimmune therapeutics plc
1
Agios pharmaceuticals, inc.
2
Albemarle corporation
1
Alkermes plc
1
Amgen inc.
7
Applied genetic technologies corporation
1
Aquestive therapeutics, inc.
1
Astellas pharma inc
2
Astrazeneca plc
7
Autolus therapeutics plc
1
Aveo pharmaceuticals, inc.
1
Bausch health companies inc.
3
Baxter international inc.
1
Becton, dickinson and company
1
Beigene, ltd.
1
Bio-rad laboratories, inc.
1
Biogen inc.
2
Biomarin pharmaceutical inc.
1
Bluebird bio, inc.
2
Boston scientific corporation
2
Bristol-myers squibb company
5
Candel therapeutics inc
1
Cellectis s.a.
1
Crinetics pharmaceuticals, inc.
1
Cti biopharma corp.
2
Cyclacel pharmaceuticals, inc.
2
Danaher corporation
1
Eli lilly and company
8
Enzon pharmaceuticals, inc.
1
Erasca inc
1
Eyepoint pharmaceuticals, inc.
1
Fusion pharmaceuticals inc.
1
Genelux corp
1
General electric company
1
Gilead sciences, inc.
2
Glaxosmithkline plc
13
Incyte corporation
7
Jazz pharmaceuticals plc
2
Johnson & johnson
13
Koninklijke philips n.v.
2
Mallinckrodt plc
3
Mei pharma, inc.
2
Morphosys ag
6
Novartis ag
83
Novo nordisk a/s
2
Pfizer, inc.
11
Precision biosciences, inc.
2
Regeneron pharmaceuticals, inc.
3
Sanofi
12
Takeda pharmaceutical company limited
9
Teva pharmaceutical industries ltd
6
Thermo fisher scientific inc
3
Uniqure n.v.
3
Viatris inc.
4
Voyager therapeutics, inc.
2
Xencor, inc.
6
Symbols
AAPL
57
ABB
65
ABBV
58
ABLZF
51
ABT
77
AEM
63
ARVL
210
BBIO
60
BDX
80
BGNE
50
BKYI
63
BMY
108
CNC
49
CSIQ
68
CSTL
67
DHR
48
DPRO
64
ERIC
82
F
57
FCN
108
FNCTF
472
GE
66
GOLD
50
GSK
74
HON
93
HUBS
458
IBM
48
INTC
50
IONS
48
J
52
JNJ
351
LLY
173
LMT
50
LTUM
121
MDT
71
MMM
54
MRK
121
MRNA
61
MS
385
MSFT
85
NVO
65
NVS
83
NVSEF
68
ORCL
119
PFE
90
PKX
51
PPRUF
68
PPRUY
68
PSN
58
REGN
50
SAP
80
SAPGF
65
SNY
344
SNYNF
257
TECH
50
TFX
56
TMO
75
TRU
83
VZ
57
WIMI
63
Exchanges
Nasdaq
78
Nyse
83
Crawled Date
2023 - 01 - 18
1
2023 - 01 - 16
1
2023 - 01 - 11
1
2023 - 01 - 04
1
2023 - 01 - 03
1
2022 - 12 - 28
1
2022 - 12 - 06
1
2022 - 12 - 05
1
2022 - 12 - 02
1
2022 - 11 - 28
1
2022 - 11 - 17
1
2022 - 11 - 15
1
2022 - 11 - 01
1
2022 - 09 - 07
1
2022 - 08 - 29
1
2022 - 08 - 19
1
2022 - 08 - 17
1
2022 - 08 - 12
1
2022 - 08 - 11
1
2022 - 08 - 02
1
2022 - 07 - 28
1
2022 - 07 - 20
1
2022 - 07 - 19
1
2022 - 07 - 01
1
2022 - 06 - 24
2
2022 - 06 - 22
2
2022 - 06 - 20
1
2022 - 05 - 27
1
2022 - 05 - 24
1
2022 - 05 - 09
1
2022 - 05 - 05
1
2022 - 05 - 03
1
2022 - 04 - 25
1
2022 - 04 - 19
1
2022 - 03 - 30
1
2022 - 03 - 14
1
2022 - 03 - 10
1
2022 - 03 - 04
1
2021 - 12 - 06
2
2021 - 11 - 02
1
2021 - 10 - 29
1
2021 - 10 - 28
1
2021 - 10 - 22
1
2021 - 10 - 13
1
2021 - 10 - 05
1
2021 - 10 - 01
1
2021 - 09 - 23
1
2021 - 09 - 17
1
2021 - 09 - 08
1
2021 - 08 - 24
1
2021 - 08 - 11
1
2021 - 08 - 05
1
2021 - 08 - 03
1
2021 - 07 - 20
1
2021 - 06 - 08
1
2021 - 05 - 10
1
2021 - 05 - 06
1
2021 - 05 - 04
1
2021 - 03 - 22
1
2021 - 03 - 07
1
Crawled Time
00:00
45
00:20
10
01:00
47
01:08
1
02:00
25
03:00
34
04:00
23
04:20
8
05:00
23
06:00
69
06:03
2
07:00
39
08:00
34
08:20
4
08:23
1
09:00
45
10:00
33
11:00
52
11:01
1
12:00
83
12:15
6
12:20
16
12:30
9
13:00
35
13:14
1
13:15
7
13:20
8
13:30
5
13:35
1
13:58
1
14:00
50
14:15
2
14:20
10
14:30
7
14:49
1
15:00
55
15:15
4
15:20
16
15:30
16
16:00
56
16:01
1
16:20
4
17:00
65
18:00
55
19:00
45
20:00
48
20:20
3
21:00
34
22:00
55
22:01
1
23:00
44
23:09
1
Source
ir.voyagertherapeutics.com
1
www.biospace.com
22
www.globenewswire.com
16
www.precisionbiosciences.com
2
www.prnewswire.com
42
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NVS
crawled time :
12:00
save search
NewAmsterdam Pharma Announces the Appointment of Juliette Audet as Chief Business Officer
Published:
2024-04-01
(Crawled : 12:00)
- globenewswire.com
NAMS
|
$19.98
2.78%
2.7%
140K
|
n/a
|
-10.51%
|
O:
6.23%
H:
2.77%
C:
-10.21%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.42%
|
O:
0.47%
H:
0.23%
C:
-0.99%
pharma
business
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
Published:
2024-03-25
(Crawled : 12:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.86%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.27%
|
O:
-0.08%
H:
0.15%
C:
-0.44%
AUTL
|
$4.51
-6.04%
-6.43%
1.4M
|
Health Technology
|
-23.1%
|
O:
2.53%
H:
1.85%
C:
-2.31%
medical
Novartis Fabhalta® (iptacopan) receives positive CHMP opinion as first oral monotherapy for adult patients with paroxysmal nocturnal hemoglobinuria (PNH)
Published:
2024-03-22
(Crawled : 12:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-3.12%
|
O:
0.17%
H:
0.28%
C:
-0.01%
fabhalta
first
chmp
positive
novartis
Alkermes Announces Appointment of Nancy S. Lurker to Board of Directors
Published:
2024-03-07
(Crawled : 12:00)
- prnewswire.com
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-6.51%
|
O:
0.04%
H:
0.44%
C:
-1.51%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.31%
|
O:
-2.08%
H:
0.13%
C:
-0.57%
BMY
|
$48.93
1.3%
0.0%
10M
|
Health Technology
|
-9.52%
|
O:
0.36%
H:
0.34%
C:
-0.54%
XFOR
|
$1.255
4.58%
4.38%
3M
|
Health Technology
|
24.55%
|
O:
0.12%
H:
0.0%
C:
-4.98%
EYPT
|
$17.665
0.94%
0.93%
1.5M
|
Health Technology
|
-15.15%
|
O:
2.56%
H:
1.37%
C:
-4.13%
AQST
|
$4.11
-8.67%
-9.49%
2.3M
|
Health Technology
|
-10.54%
|
O:
1.79%
H:
12.3%
C:
10.94%
ALKS
|
$23.86
0.42%
0.42%
2.4M
|
Health Technology
|
-17.9%
|
O:
1.11%
H:
0.96%
C:
0.65%
Clinical trials market size in US to grow by USD 5.9 billion from 2022 to 2027, The rise in the number of clinical trials of drugs is the key factor driving market growth, Technavio
Published:
2024-03-06
(Crawled : 12:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.01%
|
O:
0.0%
H:
0.8%
C:
0.8%
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
-8.83%
|
O:
0.64%
H:
1.7%
C:
0.54%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.83%
|
O:
0.2%
H:
0.71%
C:
0.33%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.29%
|
O:
-0.45%
H:
0.0%
C:
0.0%
ICLR
|
$288.32
-1.2%
-1.21%
640K
|
Health Technology
|
-12.96%
|
O:
2.54%
H:
0.22%
C:
-2.44%
trials
key
market
Voyager Therapeutics Enters Capsid License Agreement and Strategic Collaboration with Novartis to Advance Novel Gene Therapies
Published:
2024-01-02
(Crawled : 12:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-7.81%
|
O:
-0.86%
H:
1.81%
C:
0.9%
VYGR
|
$7.5
-0.66%
-0.67%
520K
|
Health Technology
|
-10.55%
|
O:
24.76%
H:
11.3%
C:
-14.53%
SGMO
|
$0.5143
6.02%
5.68%
1M
|
Health Technology
|
-4.29%
|
O:
-0.17%
H:
9.33%
C:
2.56%
NBIX
M
|
$132.03
-0.39%
-0.39%
560K
|
Health Technology
|
1.12%
|
O:
-1.18%
H:
2.4%
C:
1.18%
license
collaboration
novartis
therapeutics
agreement
Bioluminescence Ventures Emerges from Stealth with $477M AUM
Published:
2023-11-01
(Crawled : 12:00)
- biospace.com/
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
2.99%
|
O:
2.52%
H:
0.04%
C:
0.04%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-0.53%
|
O:
0.16%
H:
0.7%
C:
0.57%
Erasca Doses First Patient in SEACRAFT-1 Phase 1b Trial Evaluating Naporafenib Plus Trametinib in Patients with RAS Q61X Solid Tumors
Published:
2023-08-29
(Crawled : 12:00)
- globenewswire.com
ERAS
|
$1.79
0.0%
570K
|
|
-26.62%
|
O:
0.0%
H:
1.52%
C:
-2.09%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.05%
|
O:
-0.18%
H:
1.41%
C:
1.1%
tumors
trial
plus
Novartis presents new long-term Leqvio® (inclisiran) data demonstrating consistent efficacy and safety beyond six years
Published:
2023-08-28
(Crawled : 12:00)
- globenewswire.com
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-8.55%
|
O:
1.06%
H:
0.06%
C:
-0.51%
leqvio
six
beyond
novartis
Telix 2023 Half-Year Results: Revenue and Earnings Growth Marks Transition to a Sustainable Commercial-Stage Company
Published:
2023-08-23
(Crawled : 12:00)
- biospace.com/
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.27%
|
O:
0.56%
H:
0.1%
C:
-0.32%
growth
Acrivon Therapeutics Announces the Appointment of Adam Levy, Ph.D., M.B.A., Experienced Biotech Investor Relations and Strategy Executive, to Senior Vice President and Head, Investor Relations and Corporate Affairs
Published:
2023-07-20
(Crawled : 12:00)
- globenewswire.com
ACRV
P
|
$9.405
-10.77%
-12.07%
630K
|
|
-21.49%
|
O:
-3.91%
H:
4.07%
C:
3.12%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
9.99%
|
O:
2.78%
H:
0.0%
C:
-1.86%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-9.82%
|
O:
1.51%
H:
0.72%
C:
0.33%
biotech
therapeutics
US FDA approves expanded indication for Novartis Leqvio® (inclisiran) to include treatment of adults with high LDL-C and who are at increased risk of heart disease
Published:
2023-07-10
(Crawled : 12:00)
- biospace.com/
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-1.74%
|
O:
1.44%
H:
0.73%
C:
0.48%
leqvio
fda
disease
treatment
risk
novartis
heart
Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027|Growing prevalence of chronic diseases to boost market growth - Technavio
Published:
2023-07-04
(Crawled : 12:00)
- prnewswire.com
AMGN
|
$269.03
2.39%
2.33%
3.4M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
News
|
$68.56
0.29%
0.29%
4.7M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
News
|
$138.24
-4.19%
800
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
$166.41
1.06%
0.0%
5.5M
|
Health Technology
|
Email alert
Add to watchlist
TMO
|
News
|
$544.78
0.6%
0.0%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
growth
market
Novartis signs agreement to divest ‘front of eye’ ophthalmology assets in line with focused strategy
Published:
2023-06-30
(Crawled : 12:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
13.52%
|
O:
1.03%
H:
0.0%
C:
-4.47%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-6.32%
|
O:
0.74%
H:
0.81%
C:
0.81%
novartis
agreement
Candel Therapeutics Appoints Experienced Manufacturing Leader Nicoletta Loggia, PhD, RPh to its Board of Directors
Published:
2023-06-08
(Crawled : 12:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.25%
|
O:
1.32%
H:
0.0%
C:
-0.62%
CADL
|
$5.17
-5.31%
-5.61%
520K
|
|
261.59%
|
O:
1.99%
H:
5.19%
C:
3.25%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-5.5%
|
O:
1.26%
H:
1.08%
C:
0.91%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
227.36%
|
O:
0.59%
H:
0.0%
C:
-2.74%
therapeutics
Novartis Kisqali® significantly reduced the risk of recurrence by 25% across a broad population of patients with early breast cancer; clinically meaningful benefit was consistent across subgroups
Published:
2023-06-02
(Crawled : 12:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
15.61%
|
O:
0.99%
H:
0.0%
C:
0.0%
PFE
A
|
$26.0
2.4%
-0.15%
38M
|
Health Technology
|
-33.14%
|
O:
0.6%
H:
1.07%
C:
0.29%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-4.15%
|
O:
1.03%
H:
0.84%
C:
0.82%
kisqali
breast
risk
novartis
Precision BioSciences Reports First Quarter 2023 Financial Results and Provides Business Update
Published:
2023-05-09
(Crawled : 12:00)
- precisionbiosciences.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
5.51%
|
O:
-2.35%
H:
1.06%
C:
0.48%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
-11.28%
|
O:
-0.38%
H:
0.39%
C:
0.18%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
73.5%
|
O:
-0.22%
H:
0.89%
C:
-0.79%
DTIL
|
$9.75
-9.05%
-9.95%
170K
|
Health Technology
|
1161.18%
|
O:
-2.94%
H:
5.45%
C:
3.03%
business
update
financial
results
Novartis Entresto receives positive CHMP opinion for pediatric heart failure
Published:
2023-03-31
(Crawled : 12:00)
- globenewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
24.64%
|
O:
-0.95%
H:
2.14%
C:
2.14%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
1.64%
|
O:
0.22%
H:
0.45%
C:
0.24%
chmp
positive
novartis
heart
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
Published:
2023-03-09
(Crawled : 12:00)
- precisionbiosciences.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
33.51%
|
O:
-5.6%
H:
1.19%
C:
1.19%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
11.75%
|
O:
-3.04%
H:
0.16%
C:
-0.9%
DTIL
|
$9.75
-9.05%
-9.95%
170K
|
Health Technology
|
832.17%
|
O:
0.87%
H:
2.59%
C:
-12.07%
year
financial
update
results
Voyager Therapeutics to Receive $25 Million Payment for License of Next-Generation AAV Capsids for Multiple Neurologic Disease Targets
Published:
2023-03-06
(Crawled : 12:00)
- ir.voyagertherapeutics.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
34.89%
|
O:
2.04%
H:
0.0%
C:
0.0%
NVS
|
$94.36
1.93%
0.0%
2.3M
|
Health Technology
|
9.92%
|
O:
0.34%
H:
0.76%
C:
-0.06%
VYGR
|
$7.5
-0.66%
-0.67%
520K
|
Health Technology
|
3.28%
|
O:
5.47%
H:
5.45%
C:
3.24%
disease
license
therapeutics
payment
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.